Psyence Biomedical Ltd. (PBM) Receivables - Other (2023 - 2026)
Psyence Biomedical (PBM) posted quarterly Receivables - Other of $109779.0 for Q1 2026, down 20.07% year-over-year from $137348.0 in Q1 2025, and down 36.98% quarter-over-quarter from $174187.0 in Q3 2025.
Psyence Biomedical Ltd. (PBM) Receivables - Other (2023 - 2026) Analysis & Trends
Psyence Biomedical's Receivables - Other history runs 4 years deep, the most recent figure standing at $109779.0 for Q1 2026.
- In Q1 2026, Receivables - Other fell 20.07% year-over-year to $109779.0; the TTM figure through Mar 2026 stood at $109779.0 (down 20.07% YoY), while the FY2026 annual figure was $109779.0, down 20.07% from the prior year.
- Receivables - Other for Q1 2026 stood at $109779.0, down from $174187.0 in the prior quarter.
- The five-year high for Receivables - Other was $174187.0 in Q3 2025, with the low at $41747.0 in Q1 2024.
- The 4-year median for Receivables - Other is $131214.0 (2024), against an average of $122918.3.
- The sharpest annual moves came in 2024 and 2025: Receivables - Other sank 72.05% in 2024, then surged 229.0% in 2025.
- Psyence Biomedical's Receivables - Other stood at $149369.0 in 2023, then slipped by 16.26% to $125080.0 in 2024, then soared by 39.26% to $174187.0 in 2025, then tumbled by 36.98% to $109779.0 in 2026.
- Business Quant data shows PBM's Receivables - Other at $109779.0 in Q1 2026, $174187.0 in Q3 2025, and $137348.0 in Q1 2025.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 109,779.00 |
| Mar 31, 2026 | 109,779.00 |
| Sep 30, 2025 | 174,187.00 |
| Sep 30, 2025 | 174,187.00 |
| Mar 31, 2025 | 137,348.00 |
| Mar 31, 2025 | 137,348.00 |
| Sep 30, 2024 | 125,080.00 |
| Sep 30, 2024 | 125,080.00 |
| Mar 31, 2024 | 41,747.00 |
| Mar 31, 2024 | 41,747.00 |
| Mar 31, 2023 | 149,369.00 |
| Mar 31, 2023 | 149,369.00 |